Precision Approaches in Radiation Synthetic Combinations (PAIRS, RP1 Clinical Trial Optional)
This is a forecasted opportunity — a pre-announcement that isn’t open for applications yet. Dates and details may change before it posts.
This is a forecasted National Institutes of Health research opportunity (PAIRS, RP1) supporting precision approaches that combine radiation therapy with other treatments in cancer research; clinica…
- Deadline
- Not specified
- Posted
- Mar 3, 2026
- Award amount
- Amount not specified
In plain English
This is a forecasted National Institutes of Health research opportunity (PAIRS, RP1) supporting precision approaches that combine radiation therapy with other treatments in cancer research; clinical trials are optional. Such awards typically fund researchers at universities, cancer centers, and research institutions. Detailed eligibility, funding amounts, and deadlines have not yet been published for this cycle.
AI-generated summary to help you decide quickly — verify the official eligibility rules before applying.
Let AI draft your application
Your first draft is free: a narrative and budget outline tailored to this grant, emailed to you. Drafts are written in a nightly batch, so it arrives by email later — not instantly on this page.
Application Kit — $49 one-time
Winner intelligence + a first-draft narrative grounded in applications that actually won. One payment, no subscription.
Get the Application Kit →Related grants
Other open grants from National Institutes of Health — soonest deadline first.
NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional)
National Institutes of Health · Amount varies · Due Oct 3, 2026
Advancing Research on the Application of Digital Health Technology to the Management of Type 2 Diabetes (R01- Clinical Trail Required)
National Institutes of Health · Amount varies · Due Oct 6, 2026
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
National Institutes of Health · Amount varies · Due Oct 14, 2026
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
National Institutes of Health · Up to $250K · Due Oct 14, 2026
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)
National Institutes of Health · Amount varies · Due Oct 14, 2026
CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)
National Institutes of Health · Up to $300K · Due Oct 16, 2026
Also listed under National Institutes of Health.
Source: public records via Grants.gov. UseGrants is an independent aggregator, not affiliated with any funding agency. Always confirm details on the official listing before applying.